Literature DB >> 2576270

Quantitative gas chromatographic-mass spectrometric analysis of acrivastine and a metabolite in human plasma.

S Y Chang1, F R Nelson, J W Findlay, L C Taylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576270     DOI: 10.1016/0378-4347(89)80031-3

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines.

Authors:  J P Desager; Y Horsmans
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 2.  Clinical pharmacology of new histamine H1 receptor antagonists.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 3.  Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders.

Authors:  R N Brogden; D McTavish
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

4.  A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma.

Authors:  J Berlin; A C King; K Tutsch; J W Findlay; P Kohler; M Collier; N J Clendeninn; G Wilding
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.